A: Patient survival according to the T1DM SPK T2DM SPK and T2DM KTA groups. | ||||
Patient Survival | T1DM SPK | T2DM SPK | T2DM KTA | p-value |
 1-y | 89.9% | 91.7% | 92.3% | < 0.01 |
 3-y | 89.9% | 83.3% | 73.1% |  |
 5-y | 88.8% | 83.3% | 69.2% |  |
B: Pancreas Graft survival according to the T1DM SPK T2DM SPK and T2DM KTA groups. | ||||
Pancreas Graft | T1DM SPK | T2DM SPK | p-value | Â |
Survival | ||||
 1-y | 83.1% | 91.7% | 0.71 |  |
 3-y | 79.8% | 83.3% |  |  |
 5-y | 78.7% | 83.3% |  |  |
C: Kidney graft survival according to the T1DM SPK T2DM SPK and T2DM KTA groups. | ||||
Kidney Graft | T1DM SPK | T2DM SPK | T2DM KTA | p-value |
survival | ||||
 1-y | 88.8% | 91.7% | 80.8% | < 0.01 |
 3-y | 85.4% | 83.3% | 65.4% |  |
 5-y | 79.8% | 83.3% | 57.7% |  |